Jane F. Apperley | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Jane F. Apperley is active.

Explore More

Publication

Featured researches published by Jane F. Apperley.

Blood | 2005

Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells

Shao-An Xue; Liquan Gao; Daniel P. Hart; Roopinder Gillmore; Waseem Qasim; A Thrasher; Jane F. Apperley; Boris Engels; Wolfgang Uckert; Emma Morris; Hans J. Stauss

Blood | 2007

Infusions of HSV-TK Engineered Donor Lymphocytes Effectively Protect Patients Undergoing Haploidentical Stem Cells Trasplantation (HSCT) from Infectious Mortality.

M.T. Lupo Stanghellini; Chiara Bonini; Elena Provasi; Massimo Bernardi; Jacopo Peccatori; Attilio Bondanza; Zulma Magnani; Serena K. Perna; Fulvio Crippa; Veronica Valtolina; Monica Salomoni; Lucia Turchetto; Salvatore Toma; Catia Traversari; Scialini Colombi; C. Gallo Stampino; Paolo Bruzzi; Luca Castagna; Jane F. Apperley; Shimon Slavin; F. Ciceri; Claudio Bordignon

Archive | 2017

Hematopoietic cell transplants for chronic myeloid leukemia: Still a role for allogeneic transplant?

Andrew J. Innes; Jane F. Apperley; Hillard M. Lazarus; Robert Peter Gale; Armand Keating; Andrea Bacigalupo; Reinhold Munker; Kerry Atkinson; Syed Ali Abutalib

Archive | 2017

need for further investigation into the effects of discontinuing imatinib therapy in those patients who wish to conceive.

Aya Kuwabara; Anna Babb; Amr R. Ibrahim; Dragana Milojkovic; Jane F. Apperley; Marco Bua; Katayoun Rezvani; John M. Goldman; David Marin

Archive | 2013

newly diagnosed patients with chronic myeloid leukemia in KIR2DS1 Dasatinib may overcome the negative prognostic impact of

Katayoun Rezvani; Nichola Cooper; John M. Goldman; Jane F. Apperley; Richard E. Clark; David Marin; Dragana Milojkovic; Kate Stringaris; Ahmad Khoder; Abdullah Alsuliman; Maria Gilleece; Stephen G. O'Brien; Letizia Foroni; Corinne Hedgley; Gareth Gerrard

Archive | 2013

chronic myeloid leukemia Factors affecting duration of survival after onset of blastic transformation of

Edward Kanfer; John M. Goldman; Jyoti Wadhwa; Richard Szydlo; Jane F. Apperley; Andrew Chase; Marco Bua; David Marin

Archive | 2013

non-permissive mismatches for hematological stem cell transplantation A T cell epitope encoded by a subset of HLA-DPB1 alleles determines

Claudio Bordignon; Katharina Fleischhauer; Edoardo Lanino; Giuseppe Bandini; Franco Locatelli; Jane F. Apperley; Andrea Bacigalupo; Daniela Lisini; Benedetta Mazzi; Silvano Rossini; Paolo Servida; Fabio Ciceri; Chiara Bonini; Anna Maria Parodi; Miryam Martinetti; Andrea Bontadini; Elisabetta Zino; Guido Frumento; Sarah Marktel; Maria Pia Sormani; Francesca Ficara; Simona Di

Archive | 2013

1 can function as targets for leukemia-reactive CTL presented epitopes of the Wilms tumor antigen - Two distinct HLA-A0201

M. Goldman; Hans J. Stauss; Ilaria Bellantuono; Liquan Gao; Suzanne Parry; Steve Marley; Francesco Dazzi; Jane F. Apperley

Archive | 2013

transplantation for chronic myeloid leukemia polymerase chain reaction predicts outcome after allogeneic stem cell - Early detection of BCR-ABL transcripts by quantitative reverse transcriptase

M. Goldman; Christopher Pocock; Francesco Dazzi; Charles G. Craddock; Jane F. Apperley; Nicholas C. P. Cross; John Eduardo Olavarria; Edward Kanfer; Richard Szydlo; Jaspal Kaeda; Katayoun Rezvani; Kate Cwynarski

ASCO Meeting Abstracts | 2006

Infusions of HSV-TK genetically modified donor lymphocytes enable a wider use of partially mismatched allogeneic transplantation by reducing infection related mortality and improving survival in high risk acute leukemia

F. Ciceri; Chiara Bonini; M.T. Lupo Stanghellini; Armando Santoro; Shimon Slavin; Jane F. Apperley; Paolo Bruzzi; Salvatore Toma; C. Gallo Stampino; Marco Bregni; Claudio Bordignon

Explore More